Fundraisings and IPOs

1 2 3 4 63
Number of results: 1241
Date Company Amount Funding type Investors Therapeutic area Type of Information
2017-04-17 Arena Pharmaceuticals (USA - CA) $79.4 million private placement Private placement
2017-04-13 Delmar Pharmaceuticals (USA - CA) $ 9 million private placement Cancer - Oncology Restructuring
2017-04-12 Polyphor (Switzerland) CHF 40 million (€ 37.43 million) private placement Varuma (Switzerland) Ingro Finanz (Switzerland) Infectious diseases Private placement
2017-04-04 Novosanis (Belgium) € 200 000 grant Interreg CrossCare (Belgium) Infectious diseases - Diagnostic Grant
2017-04-04 Repositive (UK) £2.5 million (€ 2.92 million) series A financing round Ananda Social Venture Fund (Germany) Force Over Mass Capital (UK) Amadeus Capital Partners (UK) Jonathan Milner Technology - Services Fundraising
2017-03-31 Osmia Pharmaceuticals (Sweden) SEK 42 million (€ 4.4 million) private placement Cancer - Oncology - Veterinary medicine Private placement
2017-03-31 Aveo Pharmaceuticals (USA - MA) $15.0 Million private placement Private placement
2017-03-30 Cidara Therapeutics (USA - CA) $6.9 million grant CARB-X (Combating Antibiotic Resistant Bacteria Accelerator) (USA) Infectious diseases Grant
2017-03-30 Tango Therapeutics (USA - MA) $55 million series A financing round Third Rock Ventures (USA - MA) Cancer - Oncology Fundraising
2017-03-30 Forge Therapeutics (USA - CA) $8.8 million grant CARB-X (Combating Antibiotic Resistant Bacteria Accelerator) (USA) Grant
2017-03-28 Nosopharm (France) €2.4 million financing round Auriga Partners (France) Kreaxi (France) Alto Invest (France) Infectious diseases Capital increase
2017-03-27 Adaptimmune (UK) $61.8 million IPO Cancer - Oncology Capital increase
2017-03-22 Vect-Horus (France) € 2.5 million fundraising Provençale et Corse, BPMed (France) CNS diseases - Neurological diseases - Neurodegenerative diseases - Cancer - Oncology Fundraising
2017-03-22 Heat Biologics (USA - NC) IPO Cancer - Oncology IPO
2017-03-22 Relief Therapeutics (Switzerland) CHF 500’000 capital increase GEM Global Yield Fund Rare diseases Fundraising
2017-03-20 Aurinia Pharmaceuticals (Canada) $173.1 million private placement Autoimmune diseases - Immunological diseases Private placement
2017-03-20 Advicenne (France) €16 million financing round IRDI SORIDEC Gestion (France) Cemag Invest (France) MI Care (Luxembourg) InnoBio Bpifrance (France) IXO Private Equity (France) private individuals. Kidney diseases - Renal diseases - Neurological diseases Fundraising
2017-03-20 Pulmocide (UK) $30.4 million series B financing round SR One (UK) Longwood Fund  SV Life Sciences (USA - MA) F-Prime Capital (USA - MA) Johnson &Johnson Innovation - JJDC (USA-NJ) Touchstone Innovations (UK) Infectious diseases - Respiratory diseases Fundraising
2017-03-17 Emergent Biosolutions (USA - MD) $100 million grant Biomedical Advanced Research and Development Authority (BARDA) (USA) Infectious diseases Grant
2017-03-15 Autifony Therapeutics (UK) £1.7 million subvention Innovate UK (UK) the Dementia Discovery Fund (UK) CNS diseases - Mental diseases Subvention